Emergent BioSolutions Inc.EBSNYSE
Loading
Income Before Tax Over TimeExpanding
Percentile Rank57
5Y CAGR-27.4%
Studio
Year-over-Year Change

Pre-tax earnings

5Y CAGR
-27.4%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$82.80M+157.9%
2024$-142.90M+80.5%
2023$-731.20M-233.9%
2022$-219.00M-172.2%
2021$303.20M-26.4%
2020$411.90M+432.2%
2019$77.40M-5.0%
2018$81.50M-31.3%
2017$118.60M+19.6%
2016$99.20M-